The New Jersey multicounty litigation court announced in a recent case management order that three more Stryker hip lawsuits have settled out of court…. Read more
Stryker Lawsuits Center
If you’ve suffered harm resulting from the implantation of a Rejuvenate or ABG II hip, then you might have a case against Stryker, the manufacturer of the device.
You’ll need to make a claim, though, and your time to do so is limited. Call us now and speak to one of our lawyers, at no cost or risk. We can determine promptly whether you have grounds for a lawsuit.
If you were harmed by a Rejuvenate or ABG II hip device, then you might be entitled to compensation for your injuries, including out-of-pocket costs, lost wages, and pain and suffering.
Don’t expect Stryker to volunteer to write you a check, though. You’ll need to demand to be made whole.
In July 2012, medical device manufacturer Stryker announced a recalling of two artificial hip implants—the Rejuvenate and the ABG II—because the modular necks on those devices are prone to fretting and corrosion, which can cause the patient’s tissue around the implant to swell and become painful. More than 2,000 people have been directly affected by the recall.
The Stryker ABG II Modular-Neck Hip Stem is a metal-on-metal hip replacement device. The U.S. FDA approved it in November 2009 via its 510(k) premarket notification process, a streamlined mechanism that allows artificial implant manufacturers to clear their products without clinical trials.
You might have heard that Stryker Corp. announced the recall of two of its metal-on-metal hip devices in June 2012, and if you received one of these implants, you will want to know if you are affected. The devices are the Rejuvenate Modular Hip Stem and the ABG II Modular-Neck Hip Stem.
When Stryker Corp. announced the recall of the Rejuvenate Modular Hip Stem and the ABG II Modular-Neck Hip Stem, it claimed it would reimburse patients for “testing, treatment, revision surgery, if necessary, and other costs” related to the recall. It might be tempting to take Stryker up on its offer…